[{"Assets_0_FY_USD":489829000.0,"CommonStockSharesOutstanding_0_FY_shares":19703000.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":71418000.0,"NetIncomeLoss_1_FY_USD":9191000.0,"NetIncomeLoss_4_FY_USD":46383000.0,"StockholdersEquity_0_FY_USD":462492000.0,"EarningsPerShareBasic_1_FY_USD":0.47,"EarningsPerShareBasic_4_FY_USD":2.37,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":19584000.0,"Ticker":"ENTA","CIK":"1177648","name":"ENANTA PHARMACEUTICALS INC","OfficialName":"Enanta Pharmaceuticals Inc. Common Stock","form":"10-K","period":"20190930","fy":"2019.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1492537180.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20191127"}]